U-Neuron Biomedical Inc (TPEX:6973)
Taiwan
· Delayed Price · Currency is TWD 36.15
0.00 (0.00%)
Apr 29, 2026, 12:08 PM CST
U-Neuron Biomedical Market Cap
U-Neuron Biomedical has a market cap or net worth of 1.07 billion as of April 29, 2026. Its market cap has decreased by -6.59% in one year.
Market Cap
1.07B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
36.15
Market Cap Chart
Since July 20, 2023, U-Neuron Biomedical's market cap has decreased from 1.36B to 1.07B, a decrease of -21.41%. That is a compound annual growth rate of -8.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.07B | -4.62% |
| Dec 31, 2025 | 1.12B | -9.44% |
| Dec 31, 2024 | 1.24B | -30.25% |
| Dec 29, 2023 | 1.77B | 30.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lukas Biomedical | 1.01B |
| Taiwan Advance Bio-Pharmaceutical | 1.03B |
| TCI GENE | 955.15M |
| Level Biotechnology | 1.09B |
| Holy Stone Healthcare | 1.12B |
| GeneReach Biotechnology | 1.13B |
| LabTurbo Biotech | 1.15B |
| NatureWise Biotech & Medicals | 897.75M |